Status:
COMPLETED
Berlin Atrial Fibrillation Registry
Lead Sponsor:
Charite University, Berlin, Germany
Collaborating Sponsors:
Center for Stroke Research Berlin
Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma
Conditions:
Acute Ischemic Stroke
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
Investigator-initiated prospective multicentre hospital-based registry to uncover the proportion of self-reported anticoagulation in stroke patients with atrial fibrillation and assessing the proporti...
Eligibility Criteria
Inclusion
- Acute ischemic stroke or transient ischemic attack (with clinical deficit on admission or corresponding brain MRI lesion)
- Age ≥ 18 years
- Known atrial fibrillation or ECG recording documenting atrial fibrillation during the in-hospital stay for acute ischemic stroke or transient ischemic attack
- Written or oral informed consent
- Willingness to take part in the planned follow up examinations
Exclusion
- Life expectancy \< 1 year (before stroke)
- Assumed post-stroke life expectancy \< 1 month according to stroke severity
- Chronic anticoagulation for reasons other than atrial fibrillation
Key Trial Info
Start Date :
December 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2020
Estimated Enrollment :
1080 Patients enrolled
Trial Details
Trial ID
NCT02306824
Start Date
December 1 2014
End Date
November 1 2020
Last Update
November 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité - Universitätsmedizin Berlin
Berlin, Germany